Happy Holidays
Tweet
In the spotlight – Ingrid Qemo
Out with the Old, In with the New! Biological aging or senescence is the steady decline of cellular function with age. There are a number of rationales that explain why senescence occurs, including changes in gene expression, or damage that is accumulated throughout the lifetime of a cell. Many questions surrounding how to overcome senescence
In the spotlight – Ingrid Qemo Read More »
In the spotlight – The Zebrafish Group
Would you ever believe that a fish no bigger than your fingernail could provide information on the best form of therapy for cancer treatments? Well, it’s true! In the Porter lab, the zebrafish group is a part of the Breast Group with our focus being on using fish, specifically zebrafish, to answer questions about which
In the spotlight – The Zebrafish Group Read More »
In the spotlight – The Breast Group
Cancer is a complex disease, and the process towards the discovery of a cure is itself complex. It is a step by step process that builds upon previous discoveries and fitting together the pieces of the puzzle until we get a complete picture. We work at understanding cancer at the most basic level, at understanding
In the spotlight – The Breast Group Read More »
In the spotlight – The Brain Group
What makes up a true neural stem cell? What controls its self-renewal and commitment? How is the symmetry of division regulated and kept in check? Can we pinpoint the origin of brain cancer? Questions about molecular mechanisms behind the regulation of cell fate within the mammalian brain have been fascinating scientists around the world for
In the spotlight – The Brain Group Read More »
In the spotlight – Tuberin group
The research in Porter Lab is divided into 4 main groups, one research associate fellow is responsible for the projects, grants, and students into each group. I’m Elizabeth Fidalgo, Ph.D., and I’m the leader of the Tuberin group. As the group name states our group studies a protein named Tuberin. This protein is a Tumour
In the spotlight – Tuberin group Read More »
In the spotlight – Dr. Lisa Porter
Why Research? The world is constantly changing, evolving and facing new obstacles; climate change, political and social adversity, barriers of equality, poverty, disease, changing population demographics – the list goes on. To the outside world, the workings of Universities are largely unknown. Higher education itself is often viewed as a machine to pump students with
In the spotlight – Dr. Lisa Porter Read More »
Porter Lab Welcomes Brain Tumour Survivors Group
Yesterday afternoon the Porter Lab welcomed members of the Brain Tumour Survivors Group to the lab. The members were treated to an exciting presentation by Dr. Lisa Porter detailing a brief history of cancer and how Porter Lab is working to advance the frontier of cancer treatment – from basic research to the development of
Porter Lab Welcomes Brain Tumour Survivors Group Read More »
Research effort to study link between shift work and colorectal cancer
It’s no secret shift work can wreak havoc on your health. A grant handed out Wednesday under a program backed by the Windsor Essex County Cancer Centre Foundation will help a University of Windsor researcher in determining any connection between shift work and colorectal cancer. “This is not to discover a drug,” said Phillip Karpowicz, an
Research effort to study link between shift work and colorectal cancer Read More »
Breast cancer study to help Windsor women first
Women in Windsor-Essex will benefit first from a new study that is trying to help women with one of the worst forms of breast cancer. University of Windsor biology researcher Lisa Porter and Windsor Regional Hospital oncologist Dr. Carolyn Hamm recently received more than $765,000 to study triple-negative breast cancer. Cancer cells from tumours from about 100
Breast cancer study to help Windsor women first Read More »